rs1062087

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014832.5(TBC1D4):​c.2455G>A​(p.Val819Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.855 in 1,613,816 control chromosomes in the GnomAD database, including 597,291 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 45590 hom., cov: 31)
Exomes 𝑓: 0.87 ( 551701 hom. )

Consequence

TBC1D4
NM_014832.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0320

Publications

37 publications found
Variant links:
Genes affected
TBC1D4 (HGNC:19165): (TBC1 domain family member 4) This gene is a member of the Tre-2/BUB2/CDC16 domain family. The protein encoded by this gene is a Rab-GTPase-activating protein, and contains two phopshotyrosine-binding domains (PTB1 and PTB2), a calmodulin-binding domain (CBD), a Rab-GTPase domain, and multiple AKT phosphomotifs. This protein is thought to play an important role in glucose homeostasis by regulating the insulin-dependent trafficking of the glucose transporter 4 (GLUT4), important for removing glucose from the bloodstream into skeletal muscle and fat tissues. Reduced expression of this gene results in an increase in GLUT4 levels at the plasma membrane, suggesting that this protein is important in intracellular retention of GLUT4 under basal conditions. When exposed to insulin, this protein is phosphorylated, dissociates from GLUT4 vesicles, resulting in increased GLUT4 at the cell surface, and enhanced glucose transport. Phosphorylation of this protein by AKT is required for proper translocation of GLUT4 to the cell surface. Individuals homozygous for a mutation in this gene are at higher risk for type 2 diabetes and have higher levels of circulating glucose and insulin levels after glucose ingestion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.2582626E-7).
BP6
Variant 13-75310080-C-T is Benign according to our data. Variant chr13-75310080-C-T is described in ClinVar as Benign. ClinVar VariationId is 130549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.906 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBC1D4NM_014832.5 linkc.2455G>A p.Val819Ile missense_variant Exon 14 of 21 ENST00000377636.8 NP_055647.2 O60343-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBC1D4ENST00000377636.8 linkc.2455G>A p.Val819Ile missense_variant Exon 14 of 21 2 NM_014832.5 ENSP00000366863.3 O60343-1

Frequencies

GnomAD3 genomes
AF:
0.754
AC:
114515
AN:
151926
Hom.:
45563
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.485
Gnomad AMI
AF:
0.989
Gnomad AMR
AF:
0.718
Gnomad ASJ
AF:
0.859
Gnomad EAS
AF:
0.809
Gnomad SAS
AF:
0.928
Gnomad FIN
AF:
0.831
Gnomad MID
AF:
0.835
Gnomad NFE
AF:
0.888
Gnomad OTH
AF:
0.763
GnomAD2 exomes
AF:
0.825
AC:
205472
AN:
249084
AF XY:
0.841
show subpopulations
Gnomad AFR exome
AF:
0.477
Gnomad AMR exome
AF:
0.687
Gnomad ASJ exome
AF:
0.871
Gnomad EAS exome
AF:
0.813
Gnomad FIN exome
AF:
0.825
Gnomad NFE exome
AF:
0.882
Gnomad OTH exome
AF:
0.839
GnomAD4 exome
AF:
0.865
AC:
1265080
AN:
1461772
Hom.:
551701
Cov.:
62
AF XY:
0.870
AC XY:
632502
AN XY:
727190
show subpopulations
African (AFR)
AF:
0.468
AC:
15661
AN:
33478
American (AMR)
AF:
0.691
AC:
30907
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.872
AC:
22792
AN:
26136
East Asian (EAS)
AF:
0.779
AC:
30912
AN:
39700
South Asian (SAS)
AF:
0.933
AC:
80434
AN:
86252
European-Finnish (FIN)
AF:
0.822
AC:
43894
AN:
53402
Middle Eastern (MID)
AF:
0.877
AC:
5056
AN:
5766
European-Non Finnish (NFE)
AF:
0.885
AC:
984374
AN:
1111940
Other (OTH)
AF:
0.845
AC:
51050
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
9695
19390
29086
38781
48476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21268
42536
63804
85072
106340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.754
AC:
114588
AN:
152044
Hom.:
45590
Cov.:
31
AF XY:
0.753
AC XY:
56006
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.485
AC:
20085
AN:
41410
American (AMR)
AF:
0.717
AC:
10954
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.859
AC:
2981
AN:
3472
East Asian (EAS)
AF:
0.809
AC:
4175
AN:
5158
South Asian (SAS)
AF:
0.928
AC:
4460
AN:
4804
European-Finnish (FIN)
AF:
0.831
AC:
8801
AN:
10596
Middle Eastern (MID)
AF:
0.833
AC:
245
AN:
294
European-Non Finnish (NFE)
AF:
0.888
AC:
60366
AN:
68010
Other (OTH)
AF:
0.766
AC:
1619
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1197
2394
3591
4788
5985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.848
Hom.:
245744
Bravo
AF:
0.732
TwinsUK
AF:
0.890
AC:
3299
ALSPAC
AF:
0.891
AC:
3433
ESP6500AA
AF:
0.504
AC:
1880
ESP6500EA
AF:
0.884
AC:
7236
ExAC
AF:
0.825
AC:
99680
Asia WGS
AF:
0.835
AC:
2904
AN:
3478
EpiCase
AF:
0.887
EpiControl
AF:
0.882

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
5.4
DANN
Benign
0.76
DEOGEN2
Benign
0.024
.;.;.;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.018
T;T;T;T;T
MetaRNN
Benign
6.3e-7
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.0
.;.;.;N;.
PhyloP100
0.032
PrimateAI
Benign
0.39
T
PROVEAN
Benign
0.020
.;N;N;N;N
REVEL
Benign
0.057
Sift
Benign
0.32
.;T;T;T;T
Sift4G
Benign
0.59
.;T;T;T;.
Polyphen
0.0
.;B;B;B;.
Vest4
0.051, 0.024, 0.0090
MPC
0.27
ClinPred
0.0027
T
GERP RS
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.011
gMVP
0.034
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1062087; hg19: chr13-75884216; COSMIC: COSV66492143; COSMIC: COSV66492143; API